By Lisa Kerner
Charlotte, N.C., June 29 - Biocrates said it closed a €5 million round of private equity financing.
Proceeds will be used to commercialize the metabolite analysis platform, application software and consumable-based products.
The investment round was led by the German MIG funds.
Biocrates is a provider of high content metabolome information and technology based in Innsbruck, Austria.
| Issuer: | Biocrates
|
| Issue: | Private equity financing
|
| Amount: | €5 million
|
| Investor: | German MIG
|
| Announcement date: | June 29
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
